Yan Shi

This inventor holds 11 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Scripps Research Institute, International Business Machines Corporation, Beihao Stem Cell and Regenerative Medicine Translational Research Institute. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yan Shi. Retrieved from https://idiyas.com/inventor/yan-shi-8fh7ykkc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 4)

% Patents Active = 90.9

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 21(Granted Patents)

Location History:

Haidian, CN (2017)
Beijing, CN (2010 - 2024)

Company Filing History:

4 out of 1,208

Scripps Research Institute

patents

3 out of 166,409

International Business Machines Corporation

patents

1 out of 1

Beihao Stem Cell and Regenerative Medicine Translational Research Institute

patent

4. 1 out of 1

Beijing Hua Yuan Bo Chuang Technology Limited

patent

5. 1 out of 1

Beijing Vitalstar Biotechnology Co., Ltd.

patent

6. 1 out of 2

National Institutes for Food and Drug Control

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11866459 - Cocrystal of progesterone and preparation method and use thereof (2024-01-09),

2. 11613735 - Methods for reprograming non-hepatocyte cells into hepatocyte cells (2023-03-28),

3. 11583570 - Use of autoinducer-related pathway in inducing apoptosis and anti-infective therapy (2023-02-21),

4. 10310919 - Dynamic queue alias (2019-06-04),

5. 10270662 - Local consumption of remote services (2019-04-23),

6. 9926533 - Combined chemical and genetic approaches for generation of induced pluripotent stem cells (2018-03-27),

7. 9771563 - Chemical approaches for generation of induced pluripotent stem cells (2017-09-26),

8. 9540615 - Combined chemical and genetic approaches for generation of induced pluripotent stem cells (2017-01-10),

9. 9534205 - Combined chemical and genetic approaches for generation of induced pluripotent stem cells (2017-01-03),

10. 9342388 - Dynamic queue alias (2016-05-17),

11. 7776597 - Method of inducing embryonic stem cells into pancreatic cells (2010-08-17),

Title: Yan Shi - Innovator in Pharmaceutical Sciences

Introduction

Yan Shi is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical sciences, holding a total of 11 patents. His work focuses on innovative methods and compounds that enhance drug efficacy and application.

Latest Patents

One of Yan Shi's latest patents is titled "Cocrystal of progesterone and preparation method and use thereof." This invention relates to a cocrystal formed by the active ingredient progesterone and a cocrystal former selected from isophthalic acid, 4-formylbenzeneboronic acid, and 3-nitrophthalic acid. The patent also details a method for preparing this cocrystal, which can be used to increase the thickness of the endometrium, improve progesterone's solubility, or enhance its permeation rate. Another notable patent is focused on "Methods for reprogramming non-hepatocyte cells into hepatocyte cells." This method induces the reprogramming of non-hepatocyte cells to express hepatic drug metabolizing and transporting capabilities, providing a valuable resource for pharmaceutical applications.

Career Highlights

Throughout his career, Yan Shi has worked with esteemed organizations such as The Scripps Research Institute and IBM. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development and cellular reprogramming.

Collaborations

Yan Shi has collaborated with notable colleagues, including Caroline Desponts and Sheng Ding. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical technologies.

Conclusion

Yan Shi's contributions to pharmaceutical sciences through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in drug development and therapeutic applications.

Profile summary based on public USPTO records.